cyclic adp-ribose has been researched along with uridine diphosphate glucose in 1 studies
| Studies (cyclic adp-ribose) | Trials (cyclic adp-ribose) | Recent Studies (post-2010) (cyclic adp-ribose) | Studies (uridine diphosphate glucose) | Trials (uridine diphosphate glucose) | Recent Studies (post-2010) (uridine diphosphate glucose) |
|---|---|---|---|---|---|
| 758 | 0 | 144 | 1,234 | 6 | 236 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ambrožová, G; Foglová, T; Hermannová, M; Kocurková, A; Kubala, L; Nešporová, K; Šimek, M; Velebný, V | 1 |
1 other study(ies) available for cyclic adp-ribose and uridine diphosphate glucose
| Article | Year |
|---|---|
How the molecular weight affects the in vivo fate of exogenous hyaluronan delivered intravenously: A stable-isotope labelling strategy.
Topics: Administration, Intravenous; Animals; Bone and Bones; Carbon Isotopes; Cartilage; Cyclic ADP-Ribose; Drug Elimination Routes; Female; Hyaluronic Acid; Isotope Labeling; Mice, Inbred BALB C; Molecular Weight; Tissue Distribution; Uridine Diphosphate Glucose; Uridine Diphosphate N-Acetylglucosamine | 2021 |